The global increase in diabetes mellitus is leading to a parallel increase in the incidence of cardiovascular complications, which remain the leading cause of death in this patient group. In recent years, the discovery of ferroptosis, an iron-dependent and non-apoptotic form of programmed cell death, has provided new insights into the pathophysiology of diabetes-associated heart disease. This review article deepens the understanding of the molecular mechanisms underlying ferroptosis in the cardiovascular system in diabetes and highlights innovative pharmacological and experimental therapeutic approaches that target ferroptosis pathways.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- From symptom to diagnosis
Abdominal pain – Hernias
- "Survey of Health, Ageing and Retirement in Europe" (SHARE)
Analysis of polypharmacy in ≥65-year-olds
- New perspectives for clinics and research
Ageing, cellular senescence and Parkinson’s disease
- From early intervention to individualization
The new guidelines at a glance
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- COPD therapy
Drug therapy – Update 2025
- Focus on prevention
Colorectal cancer screening – an update
- From symptom to diagnosis